Alivus Life Sciences Share Price

    NSE
    1075
    +60.40 (5.84%)
    ALIVUS • 14 Jul, 2025 | 03:29 PM
    BUY

    1Y Annualised Return

    26.93%

    3Y Annualised Return

    31.93%

    The current prices are delayed, login or Open Demat Account for live prices.

    Alivus Life Sciences Stock Performance

    1W Return6.05
    1Y Return26.93
    Today's Low1009.1
    Prev. Close1,014.60
    Mkt Cap (Cr.)13,156.88
    1M Return5.79
    3Y Return131.03
    52-Week High1335.1
    Open1,011.10
    PE Ratio27.11
    6M Return0.69
    Today's High1085
    52-Week Low819.05
    Face Value2

    Alivus Life Sciences Company background

    Founded in: 2011
    Managing director: Yasir Yusufali Rawjee
    Alivus Life Sciences Limited was initially established as Zorg Laboratories Private Limited, on June 23, 2011 and was granted the Certificate of Incorporation by the Registrar of Companies, Maharashtra in Pune. Subsequently, the Company was acquired by Glenmark Pharmaceuticals Limited through a Share Purchase Agreement dated 04 July 2018 and the name of the Company was changed to Glenmark Life Sciences Private Limited and a fresh Certificate of Incorporation dated 28 August 2018 was issued by the RoC. The name of the Company has now changed to Alivus Life Sciences Limited on January 20, 2025. Nirma Limited is a Subsidiary of the Company. The Company is engaged in the business of development, manufacture and marketing of Active Pharmaceutical Ingredients(APIs). In 2001, Glenmark Pharmaceuticals established its API business. The first product registered with USFDA in 2003. The Company acquired Glaxo SmithKlines (GSK) API manufacturing plant in Ankleshwar, Gujarat in 2003. It established manufacturing plant at Kurkumbh, Maharashtra in 2002. In 2004, it commenced manufacturing at Mohol, Maharashtra. In 2013, the Company commenced manufacturing at Dahej, Gujarat. The Company acquired API Division of Glenmark Pharmaceuticals Limited (the parent company) on 01 January, 2019. The Company increased its API manufacturing capabilities by enhancing the existing production capacities at Ankleshwar Dahej facilities in FY 2023, by an aggregate annual total installed capacity of 640 KL.The Company expanded projects with additional 240 KL at Dahej in 2023. The brownfield expansion at Dahej for Oncology Plant was completed. Out of the 2 independent modules, one module commissioned 100%. 192 KL out of the 400 KL intermediate manufacturing block at Ankleshwar commissioned in 2023. The Company came up with an IPO of 21,022,222 Equity Shares comprising a Fresh Issue of 14,722,222 Equity Shares and Offer for Sale of 6,300,000 Equity Shares aggregating to Rs 1513.6 Crores in August, 2021.FY24 ushered in a new chapter with Nirma Limited, a diversified conglomerate with interests in consumer products, cement, chemicals, and pharmaceuticals, acquiring a majority stake in GLS. In FY 202324, 75% of the equity stake of the Company was transferred by the promoter, Glenmark Pharmaceuticals Limited (GPL) to Nirma Limited, which completed on March 6, 2024. Resulting this, there was a change in ownership status via share purchase agreement, and Nirma became the new promoter of the Company.

    As of 14 Jul, 2025, Alivus Life Sciences share price is ₹1072.9. The stock opened at ₹1011.1 and had closed at ₹1014.6 the previous day. During today’s trading session, Alivus Life Sciences share price moved between ₹1,009.10 and ₹1,085.00, with an average price for the day of ₹1047.05. Over the last 52 weeks, the stock has recorded a low of ₹819.05 and a high of ₹1,335.10. In terms of performance, Alivus Life Sciences share price has increased by 5.3% over the past six months and has increased by 26.93% over the last year.

    Read More
    Alivus Life Sciences SIP Return Calculator

    Over the past

    1 year
    3 years
    Total Investment of ₹65,00,000
    Would have become ₹74,62,697 (+14.81%)
    Daily SIP of 25,000 would have become 74,62,697 in 1 year with a gain of 9,62,697 (+14.81%)
    View details of Market Depth

    Alivus Life Sciences Fundamental

    Market Cap (in crs)

    13,156.88

    Face Value

    2

    Turnover (in lacs)

    3,264.51

    Key Metrics

    Qtr Change %
    30.99% Gain from 52W Low
    11.2
    Dividend yield 1yr %
    0

    Top Mutual Fund Invested in Alivus Life Sciences

    Promoter
    75%
    Foreign Institutions
    6.6%
    Mutual Funds
    3.6%
    Domestic Institutions
    5.2%
    Public
    13.2%
    Promoter
    75%
    Foreign Institutions
    6.7%
    Mutual Funds
    3.2%
    Domestic Institutions
    4.9%
    Public
    13.4%
    Promoter
    75%
    Foreign Institutions
    7.8%
    Mutual Funds
    2.8%
    Domestic Institutions
    4.2%
    Public
    13%
    Promoter
    82.8%
    Foreign Institutions
    4.8%
    Mutual Funds
    1%
    Domestic Institutions
    1.6%
    Public
    10.8%
    Promoter
    82.8%
    Foreign Institutions
    5%
    Mutual Funds
    0.9%
    Domestic Institutions
    1.4%
    Public
    10.7%
    Promoter
    82.8%
    Foreign Institutions
    4.6%
    Mutual Funds
    0.6%
    Domestic Institutions
    0.7%
    Public
    11.8%

    Alivus Life Sciences Technical Analysis

    Moving Averages Analysis
    1075
    Current Price
    Bullish Moving Averages
    16
    Bearish Moving Averages
    0
    5Day EMA
    1,034.80
    10Day EMA
    1,025.40
    12Day EMA
    1,023.70
    20Day EMA
    1,022.60
    26Day EMA
    1,024.60
    50Day EMA
    1,034.40
    100Day EMA
    1,043.50
    200Day EMA
    1,027.90
    5Day SMA
    1,024.70
    10Day SMA
    1,022.80
    20Day SMA
    1,012.40
    30Day SMA
    1,015.40
    50Day SMA
    1,053.00
    100Day SMA
    1,039.80
    150Day SMA
    1,051.90
    200Day SMA
    1,061.60
    Delivery & Volume

    Delivery & Volume

    PeriodCombined Delivery VolumeNSE+BSE Traded Volume
    Day Rs
    126109 Rs
    312219 Rs
    Week Rs
    46716 Rs
    109111 Rs
    Month Rs
    47163 Rs
    96620 Rs
    1,055.67
    Pivot
    Resistance
    First Resistance
    1,102.23
    Second Resistance
    1,131.57
    Third Resistance
    1,178.13
    Support
    First Support
    1,026.33
    Second support
    979.77
    Third Support
    950.43
    Relative Strength Index
    62.09
    Money Flow Index
    67.83
    MACD
    -0.89
    MACD Signal
    -7.68
    Average True Range
    34.10
    Average Directional Index
    13.19
    Rate of Change (21)
    5.79
    Rate of Change (125)
    6.11
    Name
    Holding Percent
    QUANT MUTUAL FUND - QUANT SMALL CAP FUND
    1.91
    POLAR CAPITAL FUNDS PLC - HEALTHCARE OPPORTUNITIES
    2.79
    MASSACHUSETTS INSTITUTE OF TECHNOLOGY
    1.23

    Alivus Life Sciences Latest News

    24 JUN 2025 | Tuesday

    Alivus Life Sciences Ltd - 543322 - Announcement under Regulation 30 (LODR)-Newspaper Publication

    23 JUN 2025 | Monday

    Alivus Life Sciences Ltd - 543322 - Shareholder Meeting / Postal Ballot-Notice of Postal Ballot

    09 JUN 2025 | Monday

    Alivus Life Sciences Ltd - 543322 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

    View More

    Alivus Life Sciences Share Price FAQs

    Alivus Life Sciences share price is ₹1075 in NSE and ₹1073.5 in BSE as on 14/7/2025.

    Alivus Life Sciences share price in the past 1-year return was 26.93. The Alivus Life Sciences share hit a 1-year low of Rs. 819.05 and a 1-year high of Rs. 1335.1.

    The market cap of Alivus Life Sciences is Rs. 13156.88 Cr. as of 14/7/2025.

    The PE ratios of Alivus Life Sciences is 27.11 as of 14/7/2025.

    The PB ratios of Alivus Life Sciences is 4.67 as of 14/7/2025

    The Mutual Fund Shareholding in Alivus Life Sciences was 3.59% at the end of 14/7/2025.

    You can easily buy Alivus Life Sciences shares in Kotak Securities by opening a demat account and getting the KYC documents verified online.

    The 52-week high and low of Alivus Life Sciences share price is ₹1335.1 and ₹819.05 as of 14/7/2025.

    Please be aware that Alivus Life Sciences stock prices are subject to continuous fluctuations due to various factors.

    Popular Stocks
    65.44
    -0.48 (-0.73%)
    134.11
    -1.17 (-0.86%)
    674.50
    -7.30 (-1.07%)
    2,581.30
    +22.60 (+0.88%)
    159.00
    -1.00 (-0.63%)
    382.30
    +0.65 (+0.17%)
    160.44
    +0.60 (+0.38%)
    270.60
    +7.25 (+2.75%)
    407.30
    -2.00 (-0.49%)
    402.55
    +5.70 (+1.44%)
    Top Gainers
    270.60
    +7.25 (+2.75%)
    3,404.70
    +43.10 (+1.28%)
    867.60
    +8.75 (+1.02%)
    244.22
    +2.46 (+1.02%)
    2,581.30
    +22.60 (+0.88%)
    Top Losers
    319.10
    -6.70 (-2.06%)
    1,576.70
    -25.80 (-1.61%)
    918.85
    -14.65 (-1.57%)
    254.25
    -4.05 (-1.57%)
    1,570.30
    -24.60 (-1.54%)
    Open Demat Account
    +91 -

    Open Demat Account
    +91 -